Does Double With Regular Monitoring Prevent Undesired Tooth Movement?

Sponsor
Pomeranian Medical University Szczecin (Other)
Overall Status
Completed
CT.gov ID
NCT05626335
Collaborator
3Shape Poland Sp.z.o.o. (Other), Koszalin University of Technology (Other)
100
1
20.2
4.9

Study Details

Study Description

Brief Summary

The goal of observational study is to learn about the stability of orthodontic treatment results in orthodontic patients during retention phase of treatment.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Intraoral scan

Detailed Description

The aim of the present study was to three-dimensionally analyze tooth movement in retention phase of treatment and wherever double effectively retention prevents it.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Does Double (Fixed and Removable Orthodontic Retention) With Regular Monitoring Prevent Undesired Tooth Movement?
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Sep 9, 2022
Actual Study Completion Date :
Sep 9, 2022

Arms and Interventions

Arm Intervention/Treatment
Study group

From all the patients meeting the inclusion criteria every third patients was randomly chosen and invited to participate in the study. Written informed consent was obtained from every participant. Thus 100 patients have agreed to participate. All fixed retainers (stainless steel braided rectangular wire) were bonded in both arches by the same experienced clinician, who subsequently made impression for thermally formed splints and delivered them on the day of debonding. The effect of each of the procedures was verified by two independent experienced clinicians. On the day of debonding, directly following retainer bonding, intraoral scans were performed (T0). The patients were invited for repeating the scans after 1 (T1), 3 (T2) and 6 months (T3). The displacements were assessed by superimposition of the scans. The patients were recommended to wear removable retainers 22h/day. They were instructed to immediately report a failure and to apply immediately to the office in case of failure.

Diagnostic Test: Intraoral scan
On the day of debonding, directly following retainer bonding, intraoral scans were performed (T0), using 3Shape Trios 4 (3Shape, Copenhagen, Denmark). The scans were repeated after a month. The patients were invited for repeating the scans after 1 (T1), 3 (T2) and 6 months (T3).

Outcome Measures

Primary Outcome Measures

  1. Tooth displacement in mm [One month after debonding]

    Measurement obtained by comparing superimposed scans

  2. Tooth displacement in mm [Three months after debonding]

    Measurement obtained by comparing superimposed scans

  3. Tooth displacement in mm [Six months after debonding]

    Measurement obtained by comparing superimposed scans

Secondary Outcome Measures

  1. Failure rate [Six months of observation]

    Registration wherever the retention failure occured

  2. Compliance rate [Six months of observation]

    Registration of patients attending to scheduled visits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Non-extraction treatment

  • No hypodontia

  • Normal occlusion after treatment (Class I occlusion), perfect alignment

  • Normal overjet and overbite

  • Double retention including fixed retainer bonded from canine to canine in both dental arches and thermally formed removable splint

Exclusion Criteria:
  • Fixed orthodontic treatment in one dental arch

  • Extraction cases

  • Patient treated with orthognathic surgery

  • Imperfect treatment result due to treatment cessation on patients demand or health issues

  • Craniofacial disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Interdisciplinary Dentistry, Pomeranian Medical Univeristy in Szczecin Szczecin Zachodniopomorskie Poland 70-111

Sponsors and Collaborators

  • Pomeranian Medical University Szczecin
  • 3Shape Poland Sp.z.o.o.
  • Koszalin University of Technology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pomeranian Medical University Szczecin
ClinicalTrials.gov Identifier:
NCT05626335
Other Study ID Numbers:
  • KB-0012/74/10/2020/Z
First Posted:
Nov 23, 2022
Last Update Posted:
Nov 23, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Pomeranian Medical University Szczecin
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 23, 2022